Trial Profile
Effects of metoprolol vs olmesartan medoxomil on microvascular outcomes in patients with stage I-II hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Nov 2012
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Metoprolol
- Indications Hypertension
- Focus Pharmacodynamics
- 16 Nov 2012 New trial record
- 04 Oct 2012 Results assessing the effects of treatment on systemic microvascular rarefaction presented at the 24th Annual Scientific Meeting of the American Society of Hypertension.
- 04 Oct 2012 Results assessing the effects of treatment on microvascular endothelial function presented at the 24th Annual Scientific Meeting of the American Society of Hypertension.